Company Analysis

Intercure Ltd. (INCR)

Nasdaq: INCR · Pharmaceutical Preparations · Herzliya, IL · filing with the SEC since 2021
Grade4.7
◀ Past 6.6● Present 5.3▶ Future 1.8
2 est.

Income statement, as filed

In thousands of Israeli new shekels (ILS), as filed; per-share figures in Israeli new shekels; share counts. The fiscal year ends in December.

The Form 20-F filed Apr 30, 2026 for the period ended Dec 31, 2025 is not in EDGAR's company facts yet; its figures here are that filing's own, read from the SEC's financial statement data sets.

Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Report filedApr 30, 2026May 1, 2025May 1, 2024May 1, 2023Apr 28, 2022··
Revenue270,200238,845355,553388,684219,67765,0358,926
Cost of revenue229,519203,252247,214229,727123,68834,6497,456
Gross profit33,18130,233105,095155,08391,13131,9751,479
Research and development3904143886321,2351,5761,710
Sales and marketing52,50754,22553,26956,53323,2148,4402,693
General and administrative40,88953,66942,61036,08227,2068,59312,073
Operating income-27,244-67,208-41,56750,62728,185-38,400-3,415
Finance income3,1292,7475,8838,170130620141
Net finance income (costs)-16,859-20,115-19,718-6,785-9,45192-3,151
Income before income taxes-44,103-87,323-61,28543,84218,734-38,308-6,566
Income tax expense-7,319-14,5302,2489311,441-2,268-673
Net income-36,784-72,793-63,53343,7497,293-36,040-5,893
Net income to non-controlling interests-1,074-4,998-1,574-1,0702,6031,191r·
Net income to shareholders-35,710-67,795-61,95944,8194,690-37,231-5,893
Earnings per share, basic-0.66-1.48-1.360.990.12-1.42-0.25
Earnings per share, diluted-0.66-1.48-1.360.990.11-1.42-0.25
Weighted average shares, basic·45,869,17745,572,68945,352,60138,492,60025,396,31223,299,407
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldifrs-full:Revenue
Cost of revenue what it cost to make or buy what it soldifrs-full:CostOfSales
Gross profit revenue less the cost of what it soldifrs-full:GrossProfit
Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense
Sales and marketing the cost of finding and serving customersifrs-full:SalesAndMarketingExpense
General and administrative the cost of running the company itselfifrs-full:GeneralAndAdministrativeExpense
Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities
Finance income what its cash and investments earnedifrs-full:FinanceIncome
Net finance income (costs) interest earned less interest paid, outside the businessifrs-full:FinanceIncomeCost
Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax
Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersifrs-full:ProfitLossAttributableToNoncontrollingInterests
Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent
Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare
Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare
Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares
SI Assistanton INCR · research, not advice